If you are interested in helping cancer patients by developing a new modality, the Neuro-Oncology Branch (NOB) at the National Cancer Institute (NCI) is a great place to take on this challenging task. Immunotherapy has changed the paradigm of cancer treatment for the last 5 years, and now it is approved to treat more than 13 cancer types. However, primary brain cancer has not received the benefit of the therapy. The NOB’s Basic Immunology program works on the challenging goal of finding a way for immunotherapy to work against primary brain cancer. The team closely collaborates with other teams, including NOB’s clinical team, to conduct multidisciplinary research with the potential for translational, clinical discoveries.

The Neuro-Oncology Branch (NOB), Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH) in Bethesda, Maryland is seeking outstanding and highly motivated postdoctoral fellow candidates for a fellowship position in laboratory research on immunology of primary brain cancer. The position is in the laboratory of NOB’s Basic Immunology program led by Masaki Terabe, Ph.D., whose goal is to develop novel immunotherapies for primary brain cancer patients. The Basic Immunology program primarily focuses on the roles of unconventional T cells, such as CD1d-restricted NKT cells and MR1-restricted MAIT cells, and other types of T cells in the regulation of tumor immunity against primary brain cancer. Candidates are expected to join a basic, translational, and collaborative research program.

The NOB also offers collaborative opportunities and resources through its various laboratory programs, encompassing areas of research in cell biology, genomics, and metabolomics, as well as its pre-clinical translational research program. For more information on NOB, please visit: https://ccr.cancer.gov/Neuro-Oncology-Branch .

The CCR is an intramural research component of the NCI. The CCR’s enabling infrastructure facilitates clinical studies at the NIH Clinical Center, the world’s largest dedicated clinical research complex; and provides extensive opportunities for collaboration with other investigators at the forefront of medical research. This environment enables scientists and clinicians to undertake high-risk, high-impact, laboratory- and clinic-based investigations. Investigators are supported by a wide array of intellectual, technological, and research resources. This includes surgical and pathology facilities; animal facilities; and dedicated, high-quality technology cores. For an overview of CCR, please visit: http://ccr.cancer.gov/ . The NCI Center of Excellence in Immunology (CEI) also provides a network of diverse intellectual, financial, and physical resources to help develop new initiatives, projects, and collaborations. For more information of CEI, please visit: https://ccrod.cancer.gov/confluence/display/COEI/Home .

vThe successful candidate must have a Ph.D. and/or M.D. degree and less than four years of postdoctoral experience. Proficiency in oral and written English is required. Applicants with a strong background in immunology, preferably in cancer immunology, with bioinformatic skills are encouraged to apply. A candidate should desirably be familiar with various types of immunological analysis. Candidates may be U.S. citizens, U.S. permanent residents, or eligible for a visa that will enable work in the U.S.

Please email curriculum vitae, statement of research interests, and three letters of reference to the attention of: Masaki Terabe, Ph.D., Neuro-Oncology Branch, National Cancer Institute, 37 Convent Drive, Building 37, Room 1016A, Bethesda, MD 20892 at terabe@mail.nih.gov .

The NIH is dedicated to building a community in its training and employment programs and encourages the application and nomination of qualified women, minorities, and individuals with disabilities.